Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Animal Blood Plasma Products and Derivatives Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Immunoglobulin
      • 1.3.3 Fibrinogen
      • 1.3.4 Serum Albumin
      • 1.3.5 Fetal Bovine Serum
    • 1.4 Market Segment by Application
      • 1.4.1 Global Animal Blood Plasma Products and Derivatives Market Share by Application (2019-2025)
      • 1.4.2 Cell Culture Media
      • 1.4.3 Food Industry
      • 1.4.4 Pharmaceutical Industry
      • 1.4.5 Sports Nutrition
      • 1.4.6 Nutrition Supplements
      • 1.4.7 Cosmetic Industry
      • 1.4.8 Diagnostic Industry
      • 1.4.9 Pet Food Industry
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Animal Blood Plasma Products and Derivatives Market Size
      • 2.1.1 Global Animal Blood Plasma Products and Derivatives Revenue 2014-2025
      • 2.1.2 Global Animal Blood Plasma Products and Derivatives Sales 2014-2025
    • 2.2 Animal Blood Plasma Products and Derivatives Growth Rate by Regions
      • 2.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Regions 2014-2019
      • 2.2.2 Global Animal Blood Plasma Products and Derivatives Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Animal Blood Plasma Products and Derivatives Sales by Manufacturers
      • 3.1.1 Animal Blood Plasma Products and Derivatives Sales by Manufacturers 2014-2019
      • 3.1.2 Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2014-2019)
      • 3.2.2 Animal Blood Plasma Products and Derivatives Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Animal Blood Plasma Products and Derivatives Market Concentration Ratio (CR5 and HHI)
    • 3.3 Animal Blood Plasma Products and Derivatives Price by Manufacturers
    • 3.4 Key Manufacturers Animal Blood Plasma Products and Derivatives Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Animal Blood Plasma Products and Derivatives Market
    • 3.6 Key Manufacturers Animal Blood Plasma Products and Derivatives Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Immunoglobulin Sales and Revenue (2014-2019)
      • 4.1.2 Fibrinogen Sales and Revenue (2014-2019)
      • 4.1.3 Serum Albumin Sales and Revenue (2014-2019)
      • 4.1.4 Fetal Bovine Serum Sales and Revenue (2014-2019)
    • 4.2 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type
    • 4.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type
    • 4.4 Animal Blood Plasma Products and Derivatives Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Animal Blood Plasma Products and Derivatives Sales by Application

    6 United States

    • 6.1 United States Animal Blood Plasma Products and Derivatives Breakdown Data by Company
    • 6.2 United States Animal Blood Plasma Products and Derivatives Breakdown Data by Type
    • 6.3 United States Animal Blood Plasma Products and Derivatives Breakdown Data by Application

    7 European Union

    • 7.1 European Union Animal Blood Plasma Products and Derivatives Breakdown Data by Company
    • 7.2 European Union Animal Blood Plasma Products and Derivatives Breakdown Data by Type
    • 7.3 European Union Animal Blood Plasma Products and Derivatives Breakdown Data by Application

    8 China

    • 8.1 China Animal Blood Plasma Products and Derivatives Breakdown Data by Company
    • 8.2 China Animal Blood Plasma Products and Derivatives Breakdown Data by Type
    • 8.3 China Animal Blood Plasma Products and Derivatives Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Animal Blood Plasma Products and Derivatives Breakdown Data by Company
    • 9.2 Rest of World Animal Blood Plasma Products and Derivatives Breakdown Data by Type
    • 9.3 Rest of World Animal Blood Plasma Products and Derivatives Breakdown Data by Application
    • 9.4 Rest of World Animal Blood Plasma Products and Derivatives Breakdown Data by Countries
      • 9.4.1 Rest of World Animal Blood Plasma Products and Derivatives Sales by Countries
      • 9.4.2 Rest of World Animal Blood Plasma Products and Derivatives Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Lake Immunogenics
      • 10.1.1 Lake Immunogenics Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.1.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.1.5 Lake Immunogenics Recent Development
    • 10.2 Auckland BioSciences
      • 10.2.1 Auckland BioSciences Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.2.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.2.5 Auckland BioSciences Recent Development
    • 10.3 Kraeber & Co. GmbH
      • 10.3.1 Kraeber & Co. GmbH Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.3.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.3.5 Kraeber & Co. GmbH Recent Development
    • 10.4 Sigma-Aldrich
      • 10.4.1 Sigma-Aldrich Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.4.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.4.5 Sigma-Aldrich Recent Development
    • 10.5 Thermo Fisher Scientific
      • 10.5.1 Thermo Fisher Scientific Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.5.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.5.5 Thermo Fisher Scientific Recent Development
    • 10.6 Rocky Mountain Biologicals
      • 10.6.1 Rocky Mountain Biologicals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.6.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.6.5 Rocky Mountain Biologicals Recent Development
    • 10.7 LAMPIRE Biological Laboratories
      • 10.7.1 LAMPIRE Biological Laboratories Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.7.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.7.5 LAMPIRE Biological Laboratories Recent Development
    • 10.8 Bovogen Biologicals
      • 10.8.1 Bovogen Biologicals Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.8.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.8.5 Bovogen Biologicals Recent Development
    • 10.9 Proliant
      • 10.9.1 Proliant Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.9.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.9.5 Proliant Recent Development
    • 10.10 ANZCO Foods
      • 10.10.1 ANZCO Foods Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Animal Blood Plasma Products and Derivatives
      • 10.10.4 Animal Blood Plasma Products and Derivatives Product Introduction
      • 10.10.5 ANZCO Foods Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Animal Blood Plasma Products and Derivatives Sales Channels
      • 11.2.2 Animal Blood Plasma Products and Derivatives Distributors
    • 11.3 Animal Blood Plasma Products and Derivatives Customers

    12 Market Forecast

    • 12.1 Global Animal Blood Plasma Products and Derivatives Sales and Revenue Forecast 2019-2025
    • 12.2 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Type
    • 12.3 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Application
    • 12.4 Animal Blood Plasma Products and Derivatives Forecast by Regions
      • 12.4.1 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Animal Blood Plasma Products and Derivatives Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Animal blood is one of the main by-products of animal slaughtering and processing. It has rich protein content and high nutritional value. Plasma protein, as an important protein material, can be used for animal feed and food processing. Studies have shown that plasma proteins are enzymatically treated to obtain hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the body. At the same time, they show antioxidant properties, inhibition of angiotensin converting enzyme activity, attenuation, and other functional properties and can be used as potential nutrients. Supplements, food additives, and nutraceuticals.
      Plasma protein is the most important solid component in plasma, and its amino acid content is rich and its nutritional value is high. At present, it is mainly processed into plasma protein powder as livestock feed or nutritional supplement, or as a raw material or additive for various food systems [11]. Studies have shown that plasma proteins are hydrolyzed by specific enzymes to produce hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the human body. At the same time, they show antioxidation, inhibition of angiotensin-converting enzyme (ACE) and attenuation. The functional properties of peptides isolated from them have been widely studied as potential nutritional supplements, food additives and nutraceuticals.
      In 2019, the market size of Animal Blood Plasma Products and Derivatives is 1030 million US$ and it will reach 1880 million US$ in 2025, growing at a CAGR of 7.9% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Animal Blood Plasma Products and Derivatives.

      This report studies the global market size of Animal Blood Plasma Products and Derivatives, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Animal Blood Plasma Products and Derivatives sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Lake Immunogenics
      Auckland BioSciences
      Kraeber & Co. GmbH
      Sigma-Aldrich
      Thermo Fisher Scientific
      Rocky Mountain Biologicals
      LAMPIRE Biological Laboratories
      Bovogen Biologicals
      Proliant
      ANZCO Foods

      Market Segment by Product Type
      Immunoglobulin
      Fibrinogen
      Serum Albumin
      Fetal Bovine Serum

      Market Segment by Application
      Cell Culture Media
      Food Industry
      Pharmaceutical Industry
      Sports Nutrition
      Nutrition Supplements
      Cosmetic Industry
      Diagnostic Industry
      Pet Food Industry

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Animal Blood Plasma Products and Derivatives status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Animal Blood Plasma Products and Derivatives manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Animal Blood Plasma Products and Derivatives are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now